CClinicalTrials.gg
CompletedNCT04452019Updated Apr 14, 2023

Use of Standing Frame and "Innowalk Pro" in Patients With TBI

An interventional study of Use of standard standing frame and Use of a new device; Innowalk Pro in Brain Injuries, sponsored by Sunnaas Rehabilitation Hospital. Completed at 1 site in Norway. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-04-14.

Sponsored by Sunnaas Rehabilitation Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This study will explore physical and physiological responses to mobilization of patients with acquired brain injuries in subacute phase using a classic standing frame and a standing device with simultaneous passive movement of legs, "Innowalk Pro".

Read the detailed description

Several studies underline the importance of early mobilization of patients with brain injuries, leading to shorter hospital stays, less contractures, and improved general function.

The routine mobilization treatment in the rehabilitation of patients with severe brain injuries in Sunnaas Rehabilitation Hospital is initial use of a tilt table where tilt angle is gradually increased, and when tolerated, standing in a classic standing frame where the patient's lower body is fixed to the device in an upright standing position.

"Innowalk Pro" is a robotic standing device where legs are fixed, but passively moved by electric motors in an upright standing position. An assumption is that standing in "Innowalk Pro" might be better tolerated at an earlier stage of rehabilitation than standing in a classic standing frame.

02

Conditions studied

  • Brain Injuries

Browse trials for

Keywords

  • standing
  • blood pressure
  • heart rate
  • surface electromyography of muscles in legs
  • perceived exertion
03

In context

Brain Injuries

2,113 studies on the registry are indexed under Brain Injuries; 385 are open to participants now.

This study's enrollment of 18 is below the median of 48 across 1,331 interventional studies indexed under Brain Injuries.

Browse Brain Injuries studies →

Lead sponsor

Sunnaas Rehabilitation Hospital is the lead sponsor of 24 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Severe brain injury / stroke \<1 year post injury.
  • Medically stable
  • Paresis in lower extremities, minimal walking function (even with personal assistance) (FIM movement (walk), score 1-2)
  • Planned stay in Sunnaas RH for a minimum of 2 weeks from time of inclusion
  • Tolerate 5 minutes in 40 degrees 'upright' position in tilt table (custom orthostasis test)
  • Body weight ≤95 kg
  • Body height ≤190 cm

Exclusion criteria

Exclusion Criteria:

  • Fractures in the lower extremities or in the columna with movement or strain restrictions or with pain.
  • Aggressive and provocative behavior that affects the ability to collaborate.
  • Other conditions where upright position is contraindicated
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Active comparator
    Standing frame

    Use of standard standing frame

    Device: Use of standard standing frame · Device: Use of a new device; Innowalk Pro

  • Experimental
    "Innowalk Pro"

    Use of a new device; "Innowalk Pro"

    Device: Use of standard standing frame · Device: Use of a new device; Innowalk Pro

Interventions

  • DeviceUse of standard standing frame

    Two training sessions in a standard standing frame, max 30 min. pr. session

  • DeviceUse of a new device; Innowalk Pro

    Two training sessions in Innowalk Pro, max 30 min pr. session

06

What researchers measure

Primary outcomes

  1. Standing time in minutes

    Tolerated maximal standing time in each standing device.

    Time frame: Up to one week

  2. Blood pressure

    Blood pressure is monitored continuously

    Time frame: Up to one week

Secondary outcomes

  1. Heart rate

    Heart rate will be monitored continuously 5 minutes before and during intervention with Polar 5000

    Time frame: up to one week

  2. Muscle activity in legs

    Any muscle activity in legs during standing session will be monitored by EMG using "Musclelab" (from "Ergotest Innovations") on vastus medialis, hamstrings, tibialis ant. and gastrocnemius muscles.

    Time frame: up to one week

  3. Spasticity

    Spasticity in knee flexors and ankle flexors will be measured by Modified Ashworth scale (0-4 where 0= no increase in tone and 4 = rigid limb)

    Time frame: up to one week

  4. Perceived exertion

    For patients who are cognitive capable, perceived exertion will be registrated on Borg Scale of perceived exertion

    Time frame: up to one week

  5. Number of patients reporting pain

    Negative impact during training

    Time frame: up to one week

  6. Rate of skin issues

    The number of patients reporting

    Time frame: up to one week

  7. Number of near faints will be registered by the staff.

    Negative impact during training

    Time frame: up to one week

07

Study locations

1 site
  • Sunnaas Rehabilitation Hospital
    Nesoddtangen, 1450, Norway
08

References and documents

Publications

  • Glickman LB, Geigle PR, Paleg GS. A systematic review of supported standing programs. J Pediatr Rehabil Med. 2010;3(3):197-213. doi: 10.3233/PRM-2010-0129. PubMed 21791851 ↗
  • Riberholt CG, Lindschou J, Gluud C, Mehlsen J, Moller K. Early mobilisation by head-up tilt with stepping versus standard care after severe traumatic brain injury - Protocol for a randomised clinical feasibility trial. Trials. 2018 Nov 8;19(1):612. doi: 10.1186/s13063-018-3004-x. PubMed 30409170 ↗
  • Riberholt CG, Thorlund JB, Mehlsen J, Nordenbo AM. Patients with severe acquired brain injury show increased arousal in tilt-table training. Dan Med J. 2013 Dec;60(12):A4739. PubMed 24355448 ↗
  • Frazzitta G, Zivi I, Valsecchi R, Bonini S, Maffia S, Molatore K, Sebastianelli L, Zarucchi A, Matteri D, Ercoli G, Maestri R, Saltuari L. Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: A Randomized Pilot Study in ICU. PLoS One. 2016 Jul 22;11(7):e0158030. doi: 10.1371/journal.pone.0158030. eCollection 2016. PubMed 27447483 ↗
  • Piene Wesche A, Strand LI, Jorgensen V, Opheim A, Hoyer E. Early mobilization of a patient with acquired brain injury using a new standing aid, the Innowalk Pro. A single subject experimental design. Disabil Rehabil Assist Technol. 2023 May;18(4):407-414. doi: 10.1080/17483107.2020.1860143. Epub 2020 Dec 23. PubMed 33355016 ↗

Individual participant data

Plan to share: Yes — Anonymous IPD will be available on request.

Supporting information: Study protocol, Icf

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04452019
Lead sponsor
Sunnaas Rehabilitation Hospital
Collaborators
Made for Movement
Responsible party
Sponsor
First posted
Jun 30, 2020
Start date
Oct 19, 2020
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Apr 14, 2023

Study contacts

Vivien Jørgensen, Phd
principal investigator · Sunnaas Rehabilitaion Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion